NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Wishbone Biotech

Wishbone Biotech

Private
BelgiumHealthcare & Life Scienceshttps://www.wishbone-biotech.com/

Last Round

Early Funding

Dec 6, 2021

Total Funding Raised

$6.05M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Wishbone Biotech is a medical device company that develops and manufactures bone graft substitute products for bone regeneration and dental implants.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

orthopedic implantsmedical devicesbone graftbiomaterialsorthobiologicsdental implantsregenerative medicinebovine hydroxyapatitexenograftreconstructive surgerypediatric orthopedicsorthopedic hardwareISO 13485

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Wishbone Biotech Comparables

Compare Wishbone Biotech with similar companies based on industry and business-model similarity.

Wishbone Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
WishBone Medical, Inc.
78%
Bone Solutions, Inc.
77%
Hydrumedical S.A.
74%

Wishbone Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingDec 6, 2021
Early FundingNov 1, 2021
AcceleratorDec 19, 2013

Key People

Founding team and executive leadership

Emilie Dory

Chief Executive Officer

Executive Team

Wishbone Biotech Investors

Notable investors and investment history

Wishbone Biotech investors
InvestorRounds
NoshaqEarly Funding
EpimedeEarly Funding
Wallonie EntreprendreEarly Funding
The FaktoryEarly Funding, Accelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 22, 2026

    Monthly visitors increased 54% MoM.

  • Apr 15, 2026

    Monthly visitors increased 53% MoM.

Wishbone Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Wishbone Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Wishbone Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersBelgium
Employee Range9
Year Founded2013
Last FundingDec 6, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.